Valuation: UCB

Market Cap 4.04TCr 4.64TCr 3.81TCr 3.47TCr 6.5TCr 4,44300Cr 6.51TCr 46TCr 18TCr 2,26300Cr 17TCr 17TCr 7,30400Cr P/E 2026 *
21.2x
P/E 2027 * 17.5x
Enterprise Value 4.07TCr 4.67TCr 3.84TCr 3.49TCr 6.55TCr 4,47700Cr 6.56TCr 46TCr 18TCr 2,28100Cr 18TCr 17TCr 7,35900Cr EV / Sales 2026 *
4.69x
EV / Sales 2027 * 3.99x
Free-Float
61.59%
Yield 2026 *
0.69%
Yield 2027 * 0.71%
1 day-6.65%
1 week-7.23%
Current month-6.78%
1 month-11.11%
3 months-20.68%
6 months-15.33%
Current year-20.34%
1 week 228.94
Extreme 228.94
252.34
1 month 228.94
Extreme 228.94
268.09
Current year 228.94
Extreme 228.94
345.39
1 year 225.65
Extreme 225.65
345.39
3 years 69.7
Extreme 69.7
345.39
5 years 68.3
Extreme 68.301062
345.39
10 years 58.42
Extreme 58.42
345.39
Manager TitleAgeSince
Chief Executive Officer 67 01/01/2015
Director of Finance/CFO 60 01/07/2020
Chief Tech/Sci/R&D Officer 59 01/05/2024
Director TitleAgeSince
Director/Board Member 55 01/01/2012
Director/Board Member 67 01/01/2015
Director/Board Member 56 24/04/2014
Change 5-day change 1-year change 3-year change Capi.($)
-6.65%-7.23% - - 4.55TCr
+1.70%+0.56%+34.83%-3.06% 7.84TCr
+12.27%+17.89%+585.18%+72.54% 6.15TCr
+0.93%+3.39%-9.58%-28.55% 5.98TCr
+0.29%-1.27%-10.95%+28.43% 4.65TCr
+1.92%+0.76%+4.33%+154.99% 4.55TCr
+1.66%+0.79%+53.73%-15.39% 3.18TCr
-0.53%+2.01%+44.05%+111.95% 2.54TCr
+1.27%+9.16%+9.50%+176.90% 2.14TCr
-0.76%-1.03%+57.98%+103.49% 1.58TCr
Average +1.22%+2.95%+85.45%+66.81% 4.29TCr
Weighted average by Cap. +1.86%+3.43%+108.20%+48.34%

Financials

2026 *2027 *
Net sales 869.48Cr 997.22Cr 818.91Cr 745.77Cr 1.4TCr 96TCr 1.4TCr 9.81TCr 3.78TCr 49TCr 3.75TCr 3.66TCr 1,57000Cr 967.67Cr 1.11TCr 911.39Cr 829.99Cr 1.56TCr 1,06300Cr 1.56TCr 11TCr 4.21TCr 54TCr 4.17TCr 4.08TCr 1,74800Cr
Net income 193.12Cr 221.5Cr 181.89Cr 165.65Cr 310.57Cr 21TCr 310.96Cr 2.18TCr 839.59Cr 11TCr 832.01Cr 813.59Cr 35TCr 232.47Cr 266.63Cr 218.95Cr 199.4Cr 373.85Cr 26TCr 374.32Cr 2.62TCr 1.01TCr 13TCr 1TCr 979.34Cr 42TCr
Net Debt 31Cr 35Cr 29Cr 26Cr 49Cr 3.36TCr 49Cr 344.61Cr 132.82Cr 1.71TCr 131.62Cr 128.71Cr 5.52TCr -180.78Cr -207.34Cr -170.26Cr -155.06Cr -290.72Cr -20TCr -291.08Cr -2.04TCr -785.91Cr -10TCr -778.81Cr -761.56Cr -33TCr
Logo UCB
UCB is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system.
Employees
9,000
Date Price Change Volume
21/26/21 $233.86 -6.65% 429
18/26/18 $250.52 +1.37% 31
17/26/17 $247.14 -0.39% 37
16/26/16 $248.11 -0.99% 121
15/26/15 $250.59 -0.60% 237
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
212.10EUR
Average target price
285.00EUR
Spread / Average Target
+34.37%

Quarterly revenue - Rate of surprise

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!